Clinical Trials About "Consensus recommendations role competencies EBMT clinical pharmacist clinical" RSS

18:29 EDT 24th June 2019 | BioPortfolio

We list hundreds of Clinical Trials about "Consensus recommendations role competencies EBMT clinical pharmacist clinical" on BioPortfolio. We draw our references from global clinical trials data listed on and refresh our database daily.

More Information about "Consensus recommendations role competencies EBMT clinical pharmacist clinical" on BioPortfolio

We have published hundreds of Consensus recommendations role competencies EBMT clinical pharmacist clinical news stories on BioPortfolio along with dozens of Consensus recommendations role competencies EBMT clinical pharmacist clinical Clinical Trials and PubMed Articles about Consensus recommendations role competencies EBMT clinical pharmacist clinical for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of Consensus recommendations role competencies EBMT clinical pharmacist clinical Companies in our database. You can also find out about relevant Consensus recommendations role competencies EBMT clinical pharmacist clinical Drugs and Medications on this site too.

Showing "Consensus recommendations role competencies EBMT clinical pharmacist clinical" Clinical Trials 1–25 of 14,000+

Extremely Relevant

Clinical Pharmacist Anticoagulant Stewardship

Initiative to improve direct anticoagulant utilization involving programmatic review by clinical pharmacists in collaboration with multidisciplinary team.


Pharmacist Role in HF Patients Transition of Care

To assess the effectiveness of pharmacist's provided education in HF patients, in improving patients' knowledge and self-efficacy, and to assess the impact of this intervention on the rate of hospital readmission and emergency visits at 30-days, 60-days and 90-days after discharge.

EBMT ADWP Prospective Non Interventional Study : AutoHSCT in SSc Patients

The purpose of this study is to assess the effectiveness of Autologous Hematopoietic Stem Cell transplantation (AHSCT) for early severe or rapidly progressive Systemic Sclerosis (SSc) as currently performed by different study protocols used across Europe in various EBMT centres through the careful recording and analysis of routinely collected clinical and biological data.

Effects of a Clinical Pharmacist Service on Health-related Quality of Life

The aim of the present study is to evaluate effects of a clinical pharmacist service on health-related quality of life and prescribing of drugs. A randomized controlled trial is performed in two internal medicine wards at Sahlgrenska University Hospital, Göteborg, Sweden.

Clinical Pharmacist-led Inpatient Anticoagulation Stewardship Program

This study aims at evaluating the implementation of clinical-pharmacist-led anticoagulation stewardship program in Egyptian tertiary hospital to promote a culture of safety around anticoagulants.

Pharmacist-led Medication Review With Follow-up on Primary Care Cardiovascular Older Adult Patients.

Hypothesis: Medication Review with follow-up can improve clinical, health related quality of life and economic outcomes. To prove this hypothesis a cluster randomized controlled trial will be held in primary care centres of the public health system of Chile. Patients of the cardiovascular disease prevention program, older than 60 years and with poly pharmacy (more than 5 drugs) will be recruited. Control group will receive usual care and the intervention arm will have medicatio...

EBMT ADWP Prospective Non-interventional Study: Post-AHSCT Management in SSC Patients (NISSC-2)

The aim of the study is to assess the effectiveness of various post-transplant treatment management approaches on clinical and immune biological responses after Autologous Hematopoietic Stem Cell transplantation (AHSCT) for Systemic Sclerosis (SSc) as currently performed by the different treatment protocols used in routine clinical practice across Europe in various EBMT centres

Effect and Associated Factors of the Clinical Pharmacy Model in the Incidence of Medical Errors

Medication errors are considered by WHO to be a subject that requires attention at all levels of care, in order to reduce the serious and preventable damage related to medication. These strategies are aimed at the patient's safety policy. In Colombia, at the regulatory level there is no standardized clinical pharmacy model where the role of the clinical pharmacist is described extensively and in detail, and in addition, data are unknown of the scope or direct effect of the inc...

Pharmaceutical Care and Clinical Outcomes for the Elderly Taking Potentially Inappropriate Medication

The investigators propose that clinical pharmacist interventions would reduce the rate of adverse drug events in elderly patients taking potentially inappropriate medication.

Impact of Clinical Pharmacist on the Quality and Cost of the Therapeutic Management of Patients in Two Medical Services of a Teaching Hospital

Incomplete information or poorly communicated to the transitional stages of the patient's drug therapy hospitalized cause medication errors. These steps are the admission, transfer within the institution and hospital discharge to home or another institution. The adequacy of the prescription recommendations of good practice is not always optimal. The cost of taking drug therapy and iatrogenic risks preventable drug-related weighs more and more heavily in health spending and in...

Rural Alberta Clinical Trial in Optimizing Hypertension

The purpose of this study is to evaluate the effect of enhanced pharmacist care (patient identification, assessment, education, prescribing/titration of antihypertensive medications and close follow-up) on systolic blood pressure (BP) reduction in patients with poorly controlled hypertension in the rural setting.

Cost-benefit Analysis of a Clinical Pharmacist Intervention

Clinical pharmacy services are vital in the prevention of adverse drug events (ADEs) in clinical practice, extending beyond the hospital to chronic disease management in outpatient settings. This study sought to evaluate the cost-benefit of a clinical pharmacy intervention in resolving treatment-related problems (TRPs) among hospital outpatients with chronic diseases. From the hospital system perspective, the cost-benefit analysis was based on a randomized clinical trial in the...

Jazz HCT Elastography

To perform an receiver operating characteristic (ROC) analysis, define a threshold and quantify the sensitivity and specificity of US SWE for risk stratification of patients into three categories as defined by the European Bone Marrow Transplant (EBMT) adult and pediatric criteria: no sinusoidal obstruction syndrome (SOS), mild to moderate SOS, and severe to very severe SOS. Secondarily, the investigators would also like to quantify the temporal relationship between US SWE chan...

Impact of Pharmacist in Cardiology Service on Diabetic Patient's Care Management

The coverage of the diabetes is a multidisciplinary care, with practitioners' implication(hospital and liberal), and other medical and paramedical profession: doctor, pharmacist, male nurse, nutritionist, etc. In fact there is a real importance of link between hospital and general medecine outside. That's why the pharmacist's presence during the hospitalization seems to be a good alternative to make the link between hospital and the outside pharmacist where patient take his tre...

Utilizing Consumer Health Informatics to Support Management of Hypertension by Clinical Pharmacists in Primary Care

The purpose of this research study is to test the feasibility, acceptability, and preliminary effectiveness of the use of a mobile pharmacist-led intervention that incorporates home BP monitoring and medication reminders with patients recruited from a primary care setting, as well as identify challenges and potential solutions to broader implementation of a mobile pharmacist-led home-based BP monitoring intervention in primary care clinics through key stakeholder interviews.

The Patient Experience of a Paramedic-Pharmacist Referral Pathway for Clinical Medication Reviews

This study seeks to understand how patients feel about their medicines before and after receiving a clinical medication review.

Pharmacist-led Intervention on Adherence in Patients Undergoing Treatment With an Oral Oncology Medication

Boston Medical Center provides care to cancer patients on oral cancer medications through the use of Boston Medical Center Specialty Pharmacy (BMC SP). The use of oral medications in cancer treatments is relatively new and unfortunately, very little is known about adherence in cancer patients. This study will evaluate the influence of a pharmacist-driven medication management program on adherence and persistence rates. Boston Medical Center's Specialty Pharmacy Adherence Progra...

The Role of a Clinical Pharmacist in Lifestyle Modification in Type 2 Diabetic Patients With Peripheral Neuropathy

The aims of this study are to determine the prevalence of diabetic peripheral neuropathy among the diabetic patients, to determine the association between the clinical profiles of the diabetic patients (diabetes type, diabetes duration, HbA1c, body mass index, hypertension, total cholesterol) and the diabetic peripheral neuropathy DPN and the rational poly pharmacy used to control pain.

Pharmacist Follow-up, a Qualitative Study of Patient Experience

A pharmacist follow-up procedure is under development. Patients with coronary heart disease (CHD) is being followed up by a pharmacist for one year with three meetings; at discharge from hospital, after three months and after one year. The evaluation is basically based on quantitative measures as achievement of therapeutic goals, number of drug related problems detected, hospitalisations etc. However, the patients' own experience with the follow-up procedure cannot be evaluated...

Long-Term Clinical Follow-Up of Children Enrolled in Stannsoporfin Clinical Trial Protocol No. 64,185-06-2(W)

The purpose of this protocol is to provide a mechanism to collect Long Term Clinical Data from those babies who participated in the primary Study 64,185-06-2(W)(WS)(ISNHP) "An Open-Label Study Of The Safety And Clinical Pharmacology Of Stanate® In Infants At-Risk For Exchange Transfusion".

Pharmacist Impact on Pneumococcal Polysaccharide Vaccination Rates in Patients With Diabetes in a Supermarket Pharmacy Chain

The goals of the study are to determine the pneumococcal polysaccharide vaccination rate in patients with diabetes before and after community pharmacist education and intervention. Assess barriers of receiving the pneumococcal polysaccharide vaccine in patients with diabetes after pharmacist education in a supermarket chain setting

A Trial on the Role of Community Pharmacist in Improving Adherence and Clinical Outcomes in Post-Infarction

The purpose of this pilot study is to evaluate the effectiveness of the active involvement of Community Pharmacists in improving adherence to medical prescriptions in patients with acute myocardial infarction (AMI), reducing the rate of adverse events and / or re-admissions due to cardiovascular disease and reducing overall health costs. The Hospital and Community Pharmacists will collaborate with each other, the patients, heart specialists and primary care physicians, througho...

Pharmacist Intervention to Reduce Drug-related Readmissions Among the Elderly

This randomized controlled trial primarily investigates if a clinical pharmacist intervention can reduce drug-related readmissions among patients >75 years. The intervention targets the transfer between hospital and primary care. In brief, the intervention includes medical chart reviews and patient interviews during a period of 180 days.

Evaluation of Pharmacist's Intervention in Improving Treatment Outcomes of Osteoarthritis Patients in Karachi, Pakistan

Osteoarthritis (OA) is an auto-immune chronic progressive deteriorating disease of the joints resulting in joint inflammation, pain and swelling that renders patients with reduced mobility and quality of life. Prevalence of knee osteoarthritis in Pakistan is 4.6%. It is believed that pharmacists can play a role in managing treatment outcomes of osteoarthritis patients by providing pharmaceutical care.

Advancing Child Competencies by Extending Supported Services (ACCESS) for Families Program

The Advancing Child Competencies by Extending Supported Services (ACCESS) for Families Program is a study funded by the National Institutes of Health to explore behavior and developmental problems among young children aging out of Early Steps (Part C). All families will participate in five evaluations in their home to learn more about their child's behavior and development. Families also may receive treatment designed to help change their child's behaviors that will be conducte...

More From BioPortfolio on "Consensus recommendations role competencies EBMT clinical pharmacist clinical"

Quick Search